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ABSTRACT
Class-specific bioreceptors are highly desirable for
recognizing structurally similar small molecules, but
the generation of such affinity elements has proven
challenging. We here develop a novel ‘parallel-and-
serial’ selection strategy for isolating class-specific
oligonucleotide-based receptors (aptamers) in vitro.
This strategy first entails parallel selection to se-
lectively enrich cross-reactive binding sequences,
followed by serial selection that enriches aptamers
binding to a designated target family. As a demon-
stration, we isolate a class-specific DNA aptamer
against a family of designer drugs known as syn-
thetic cathinones. The aptamer binds to 12 diverse
synthetic cathinones with nanomolar affinity and
does not respond to 11 structurally similar non-target
compounds, some of which differ from the cathinone
targets by a single atom. This is the first account
of an aptamer exhibiting a combination of broad
target cross-reactivity, high affinity and remarkable
specificity. Leveraging the qualities of this aptamer,
instantaneous colorimetric detection of synthetic
cathinones at nanomolar concentrations in biolog-
ical samples is achieved. Our findings significantly
expand the binding capabilities of aptamers as class-
specific bioreceptors and further demonstrate the
power of rationally designed selection strategies for
isolating customized aptamers with desired bind-
ing profiles. We believe that our aptamer isolation
approach can be broadly applied to isolate class-
specific aptamers for various small molecule fami-
lies.
INTRODUCTION
It is highly advantageous to be able to sensitively detect
multiple different members of a particular molecular fam-
ily or class in many analytical contexts––for example, de-
tecting illicit drugs and their metabolites for forensic inves-
tigations, antibiotics for food safety or pesticides for envi-
ronmental monitoring (1–3). Cross-reactive assays that can
broadly detect small molecules based on a shared molecu-
lar framework offer a more efficient and cost-effective so-
lution to this problem than the tandem use of multiple
highly specific assays that each detects an individual an-
alyte. Antibody-based immunoassays have dominated the
field of small-molecule detection (4), and while assays have
been developed for a wide variety of individual targets, the
development of class-specific immunoassays has proven dif-
ficult (5,6). This is in part because the process of antibody
generation, which is performed in vivo, provides no control
over the target-binding affinity and spectrum of the result-
ing antibody. Nucleic acid-based affinity reagents known
as aptamers hold much promise in circumventing many of
the shortcomings associated with antibodies (7). Aptamers
are isolated through a process termed systematic evolution
of ligands by exponential enrichment (SELEX) (8) to bind
targets of interest with high affinity and specificity. Un-
like antibodies, aptamers can be isolated relatively quickly
and chemically synthesized in an inexpensive manner with
no batch-to-batch variation. Moreover, aptamers are ther-
mostable and have shelf lives of a few years at room temper-
ature (9).
Theoretically, since SELEX is an in vitro process, the se-
lection strategy and conditions can be precisely controlled
to isolate class-specific aptamers that can broadly bind
to small molecules sharing the same core structure. How-
ever, little work has been done to demonstrate the capa-
bility of SELEX to achieve such a goal. Aptamers iso-
lated for a given small-molecule target often have innate
cross-reactivity to analogs of that molecule, but the target-
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binding spectra of these aptamers are often either insuffi-
cient and/or unpredictable. For example, one heavily stud-
ied cocaine-binding aptamer (10) can also bind to metabo-
lites such as norcocaine and cocaethylene, but does not
respond to the major metabolite benzoylecognine, which
only differs from cocaine by a single methyl group (11,12).
Toggle-SELEXwas developed as a solution to isolate cross-
reactive aptamers (13). In this strategy, a library pool is
challenged with two different targets sharing the same core
structure, which are alternated every round to select for an
aptamer that can cross-react to both targets––and ideally,
target analogs sharing the same core structure. This method
has led to the isolation of cross-reactive aptamers for a
few structurally related small molecules (14–16). However,
these aptamers typically exhibit only limited cross-reactivity
(14,15), and the overall success rate of such approaches has
been low (16). For example, Derbyshire et al. successfully
isolated an aptamer that can bind to eight aminoglycoside
antibiotics using Toggle-SELEX. Out of four independent
selections with four different target pairs, only one yielded
the final aptamer (16). The limitations of Toggle-SELEX
could be attributed to two reasons. First, in previously re-
ported approaches, only a fraction of possible substituent
positions was varied between the two targets, yielding ap-
tamers with narrow target-binding spectra. Second, since
only a small portion of the aptamers in the initial pool are
cross-reactive compared to those that bind to at least one
target, those cross-reactive aptamers could be lost during
Toggle-SELEX.
To overcome these problems, we have developed a new
‘parallel-and-serial’ selection strategy for SELEX to iso-
late class-specific aptamers for small molecule families. Our
strategy has three steps that are crucial for its success. First,
a set of structurally related targets are selected to define the
core structure that is to be recognized by the isolated ap-
tamer. The use of these targets creates selection pressure
for aptamers that recognize generic molecular features com-
mon to all targets while remaining insensitive to periph-
eral substituents. Accordingly, it is important to choose as
many targets as needed to represent variations at all desired
substituent sites while preserving the core molecular frame-
work of the target family. Next, these various targets are
employed in a parallel selection process, in which multiple
aptamer pools are enriched using each individual target. As
a result, cross-reactive aptamers recognizing the shared core
structure are enriched in all of the resulting pools after a few
rounds of selection. When all these parallel pools are com-
bined, the population of such aptamers should be relatively
high. Finally, this combined pool is subjected to serial selec-
tion with each target sequentially, a process that ultimately
retains only those aptamers that bind to the core structure
shared by these targets. Importantly, this selection strategy
is supplemented with a well-designed counter-SELEX pro-
cedure (17) to further define the targeted core structure and
to prevent the aptamer from binding to structurally similar
non-target molecules.
As a demonstration of this strategy, we isolated a class-
specific aptamer for synthetic cathinones, a large family
of dangerous designer drugs (18) that are associated with
many severe psychological and physiological health conse-
quences (19,20). The isolated aptamer demonstrated low
nanomolar binding affinity to 12 synthetic cathinones while
having no response to 11 structurally similar non-cathinone
molecules. Analysis of the aptamer isolation process via
high-throughput sequencing revealed that cross-reactive se-
quences were enriched during parallel selection, and that
exponential enrichment of such aptamers occurred dur-
ing serial selection. The target-binding spectrum of the ap-
tamer was further evaluated via a dye-displacement sens-
ing platform. Impressively, the aptamer enabled instanta-
neous colorimetric detection of several synthetic cathinones
at nanomolar concentrations in biological samples, rivaling
the performance of any currently available immunoassays
that can only detect a few members of this family. To our
knowledge, this is the first demonstration of using a ratio-
nally designed strategy to isolate high-affinity aptamers that
are truly class-specific, having both broad target-binding
spectrum as well as excellent specificity. Such success shows
that the customizable nature of SELEXmakes it well-suited
for sourcing receptors with specific, yet broad molecular
recognition capabilities, and that the approach described
herein can be generally employed to directly isolate class-
specific aptamers for any small-molecule family.
MATERIALS AND METHODS
SELEX strategy
The isolation of aptamers was carried out via a parallel-
and-serial selection strategy. The whole aptamer isolation
process consisted of five (for ethylone and butylone) or
nine (for alpha-pyrrolidinopentiophenone, -PVP) rounds
of parallel selection and two cycles of serial selection. De-
tailed information regarding the conditions for each round
of selection are listed in Supplementary Table S1. Since each
sequence has a low copy number at the beginning of SE-
LEX, high target concentrations were used during the first
few rounds to ensure retention of all possible target binders.
Moreover, for counter-SELEX, counter-target concentra-
tions were initially kept low to remove high-affinity in-
terferent binders while avoiding loss of target binders. In
later rounds of SELEX, selection stringency was increased
by decreasing the target concentration and increasing the
counter-target concentration; this was done to obtain ap-
tamers with high target affinity and specificity. The counter-
SELEX protocol was rationally designed to encompass
known and commonly observed interferents found in seized
drug samples, including cutting agents (e.g. caffeine and
acetaminophen), adulterants (e.g. procaine, lidocaine and
promazine), other illicit drugs (e.g. cocaine and metham-
phetamine) or structurally related non-cathinone molecules
(e.g. amphetamine, pseudoephedrine and ephedrine) to en-
sure that the isolated aptamer did not bind to them.
Parallel selection
Parallel selection began with three initial pools consisting
of 1 nmole DNA library (Supplementary Table S2) for each
of the three different selection targets (-PVP, ethylone and
butylone). From Round P2 to P9, ∼300 pmole of enriched
library pool for each target from the previous roundwas em-
ployed in the subsequent round. Positive selection was per-
formed with progressively decreasing target concentrations
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(Round P1: 1mM,Rounds P2–P3: 500M,Rounds P4–P5:
250 M for -PVP, ethylone and butylone; Rounds P6–P9:
100M for -PVP only) to increase selection stringency for
the enrichment of strong binders. For every round after the
first, counter-SELEXwas performed prior to positive selec-
tion in order to eliminate non-specific binders. The number
and concentrations of counter-targets were progressively in-
creased during the selection process to increase selection
stringency. Specifically, from Rounds P2–P5 for the ethy-
lone and butylone pools and Rounds P2–P8 for the -PVP
pool, we used the following counter-SELEX strategy: 100
M cocaine for Round P2, a mixture of 100 M cocaine
and 100 M procaine for Round P3, and a mixture of 100
M cocaine, 100 M procaine and 100 M lidocaine for
Rounds P4–P8. For Round P9 for the -PVP pool, 300 M
each of cocaine, procaine and lidocaine was employed con-
secutively for counter-SELEX (Supplementary Table S1).
Serial selection
We combined 100 pmole each from the P5 parallel pools for
ethylone and butylone and the P9 parallel pool for -PVP
to generate the initial pool for serial selection. Two cycles
of serial selection (Cycle 1 comprising Rounds S1–S3, Cy-
cle 2 comprising Rounds S4–S6) were performed to specifi-
cally isolate cross-reactive aptamers. For each cycle, positive
selection was performed by alternating the selection target
(Rounds S1 and S4: butylone, Rounds S2 and S5: ethylone
and Rounds S3 and S6: -PVP). Target concentration was
maintained at 100 M for each round of serial selection for
maximum stringency. In the first cycle of serial selection,
counter-SELEXwas performed prior to each round of posi-
tive selection by consecutively challenging the pool with 500
M each of cocaine, procaine and lidocaine, while in the
second cycle of serial selection, counter-SELEX was per-
formed by sequentially challenging with a mixture of 500
M each of ephedrine, pseudoephedrine, acetaminophen,
methamphetamine and amphetamine; then with a mixture
of 1mMeach of cocaine, procaine and lidocaine; and finally
with 500 M promazine (Supplementary Table S1).
SELEX procedure
The isolation of aptamers was carried out following a previ-
ously reported library-immobilized SELEX protocol (21).
The initial single-stranded DNA library used for SELEX
consisted of approximately 6 × 1014 oligonucleotides. Each
library strand is stem–loop structured and 73 nucleotides
in length, with a randomized 30-nt loop flanked in turn
by a pair of 8-nt stem-forming sequences and two primer-
binding regions (Supplementary Table S2, DNA library).
For each round of SELEX, the library/pool was mixed
with biotinylated capture strands (Supplementary Table S2,
cDNA-bio) at a molar ratio of 1:5 in selection buffer (10
mM Tris–HCl, 0.5 mM MgCl2, 20 mM NaCl, pH 7.4),
heated at 95◦C for 10 min and cooled at room temperature
for over 30 min to ensure hybridization between library and
capture strands. A micro-gravity column (0.5 ml) was pre-
pared by adding 250l of streptavidin-coated agarose beads
followed by three washes with 250 l of selection buffer.
About 250 l of cDNA-library solution was then flowed
through the micro-gravity column three times in order to
conjugate the library to the agarose beads (Supplemen-
tary Figure S1A). The column was subsequently washed
10 times with selection buffer. Then, 250 l of target (-
PVP, ethylone or butylone) dissolved in selection buffer was
added to the column. Library molecules that bound to the
target underwent a conformational change, which caused
them to detach themselves from the biotinylated cDNA into
solution (Supplementary Figure S1B). The eluent contain-
ing these strands was collected. This process was repeated
twice, and all eluents were combined (750 l total). The re-
sulting pool was concentrated via centrifugation using a 3
kDa cut-off spin filter. The concentrated pool (100 l) was
then mixed with 1 ml of GoTaq Hot Start Colorless Mas-
ter Mix with 1 M forward primer (Supplementary Table
S2, FP) and 1 M biotinylated reverse primer (Supplemen-
tary Table S2, RP-bio) to amplify the pool via polymerase
chain reaction (PCR). Amplification was performed using
a BioRad C1000 thermal cycler with conditions as follows:
2 min at 95◦C; 13 cycles of 95◦C for 15 s, 58◦C for 30 s
and 72◦C for 45 s, and 5 min at 72◦C. The optimal num-
ber of amplification cycles was determined by performing
pilot PCR to ensure sufficient amplification of enriched se-
quences without generating PCR-related artifacts. Ampli-
fication of the enriched pool and the absence of byprod-
ucts were confirmed using 3% agarose gel electrophoresis.
If byproducts with differing lengths from the original li-
brary strands were observed, the pool was purified with
a 4% agarose gel and the 73-nt products were recovered
by silica column as reported previously (21). To generate
single-stranded DNA from the resulting double-stranded
PCR products, a fresh micro-gravity column was prepared
containing 250 l streptavidin-coated agarose beads, as de-
scribed above. The amplified pool was then flowed through
the column three times to conjugate the pool to the beads.
Afterward, the column was washed six times with 250 l
of separation buffer (10 mM Tris–HCl, 20 mM NaCl, pH
7.4). The column was then capped, and 300 l of a 0.2 M
NaOH solution was added to the column and incubated for
10 min to generate single-stranded DNA, after which the
eluent was collected. An additional 100 l of 0.2 M NaOH
was added to elute residual library strands from the col-
umn. Both eluents were combined and neutralized with 0.2
MHCl, and the pool was then concentrated via centrifuga-
tion with a 3 kDa cut-off spin filter. For every round after
the first, counter-SELEXwas performed before the positive
selection step. Specifically, the library-immobilized column
was washed with 250 l of counter-target(s) in selection
buffer to remove non-specific DNA strands. This process
was performed three times for Rounds P1–P3 and S1–S6,
and ten times for Rounds P4–P5 and, in the case of -PVP,
Rounds P4–P9. Afterward, the columnwaswashed 30 times
with selection buffer to wash away non-specific binders in
preparation for positive selection.
Gel elution assay
The enrichment, target affinity, specificity and cross-
reactivity of the pools collected after Rounds P5 (for -
PVP, ethylone and butylone), P9 (for -PVP only), S3 and
S6 were evaluated using a modified version of a previously
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reported gel elution assay (Supplementary Figure S2) (22).
Specifically, 50 pmole of enriched library (Supplementary
Figure S2A) was incubated with 250 pmole of biotinylated
cDNA in 125 l of selection buffer, heated at 95◦C for 10
min and cooled at room temperature over 30 min to anneal
both strands and form cDNA-library complex (Supplemen-
tary Figure S2B). Afterward, a microcentrifugation col-
umn was prepared by adding 125 l of streptavidin-coated
agarose beads. The cDNA-library complex was then added
to the column and immobilized on the beads (Supplemen-
tary Figure S2C), and the eluent was collected and recycled
through the column twice more. The library-immobilized
agarose beads were transferred into a microcentrifugation
tube and washed five times by adding 625 l of selection
buffer, incubating on an end-over-end rotator for 5 min, fol-
lowed by centrifugation and removal of the supernatant.
The volume of the library-immobilized bead solution was
adjusted to 150 l with selection buffer and aliquoted into
seven tubes (20 l/tube). Afterward, 50 l of target at a
variety of final concentrations (0, 10, 50, 100, 250, 500 or
1000 M) was added into each tube (Supplementary Fig-
ure S2D). After rotating for 60 min on an end-over-end ro-
tator at room temperature, the beads were settled by cen-
trifugation and 40 l of the supernatant, which contained
the target-eluted strands, was collected and set aside (Sup-
plementary Figure S2E). Meanwhile, the leftover solution
(30 l) (Supplementary Figure S2F) was mixed with 50 l
of a 98% formamide solution containing 10mMethylenedi-
aminetetraacetic acid and incubated at 90◦C for 10 min to
completely release all DNA strands from the beads (Sup-
plementary Figure S2G). The resulting solution contained
both leftover target-eluted strands and non-target-eluted
strands. We analyzed the target-eluted aptamer solution
and formamide-treated library solution via 15% denatur-
ing polyacrylamide gel electrophoresis (PAGE) and deter-
mined the concentrations of the strands based on standard-
ized concentrations of ladder loaded in the gel. The elution
percentage was calculated using the equation:
θ = V1 × cs
V2 × cs + V3 × cb × 100%
where θ is the fraction of target-eluted strands, cs is the con-
centration of target-eluted strands in the supernatant, cb is
the concentration of strands in the formamide solution, V1
is the volume of solution before supernatant collection (es-
timated as 62l, with∼8l occupied by agarose beads),V2
is the volume of the collected supernatant containing target-
eluted strands (40 l) andV3 is the volume of solution after
addition of formamide (80 l). A calibration curve was cre-
ated by plotting the fraction of eluted strands against the
employed target concentration. The resulting curve was fit-
ted with the Langmuir equation to determine the dissoci-
ation constant (KD) of the enriched pool. The same pro-
tocol was used to determine the target cross-reactivity and
specificity of the enriched pool for other synthetic cathi-
nones (4-MMC, 4-FMC,MDPBP,MDPV,MePBP, methe-
drone, methylone, MPHP, naphyrone, pentylone and py-
rovalerone) or interferents (acetaminophen, amphetamine,
caffeine, cocaine, ephedrine, lidocaine, methamphetamine,
procaine, promazine, pseudoephedrine and sucrose).
Figure 1. Isolation of a class-specific aptamer using a parallel-and-serial
selection strategy. (A) The core structure of synthetic cathinones and the
three targets chosen for parallel-and-serial selection, with substituent moi-
eties shaded in red. (B) Schematic diagram of parallel-and-serial selection.
Each of the three targets was subjected to parallel selection to enrich for
broadly synthetic cathinone-specific aptamers (top), after which the result-
ing pools were combined and subjected to serial selection screening (bot-
tom) to eliminate target-specific binders while retaining those aptamers
with broad cross-reactivity for this drug class.
High-throughput sequencing (HTS) analysis of the aptamer
isolation process
High-throughput sequencing (HTS) of the four final par-
allel pools and two serial pools was performed using Ion
Torrent Sequencing. To prepare samples for sequencing, 10
nM pool was mixed with GoTaq Hot Start Colorless Mas-
ter Mix, 1 M forward primer and 1 M reverse primer
with a final volume of 50 l. Nine cycles of PCR was then
performed with the same PCR conditions as described in
‘SELEXProcedure’. Then 40l of PCR product was added
into 16l of ExoSAP-IT reagent in an ice bath. Themixture
was then incubated at 37 ◦C for 15 min to degrade remain-
ing primers and nucleotides, followed by incubation at 80◦C
for 15 min to inactivate ExoSAP-IT reagent. HTS was per-
formed at FIU DNA Core Facility using an Ion Personal
Genome Machine System with an Ion 318 v2 chip (Ther-
moFisher Scientific). Upon obtaining the sequencing data,
the primer sequences were trimmed by cutadapt (23), and
the population of sequences from each pool were calculated
using FASTAptamer (24). Members of the SCA2.1 family
are defined as sequences containing ‘AGTGGGGTTCGG
GTGGAGTT’ in any position in the 30-nt random region.
The total reads for each pool are: ethylone P5: 234428, ethy-
lone P8: 251376, butylone P5: 532967, a-PVP P9: 328474,
S3: 297379, S5: 1575678.
RESULTS
Choosing targets for selection
Synthetic cathinones share the same -keto phenethy-
lamine chemical core structure and typically differ at four
substituent sites (Figure 1A, core structure). Performing
selection directly against this ‘bare core’ (i.e. 2-amino-
propiophenone, also known as cathinone) may yield ap-
tamers with high affinity toward cathinone, but there is
no guarantee that such aptamers will bind other synthetic
cathinones that have different substituents on the core struc-
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ture. This is supported by previous studies that showed that
small molecule-binding aptamers isolated for a single tar-
get often have lower or no affinity for compounds with
additional/differing substituents (17,25). We rationalized
that performing SELEX with a set of structurally similar,
yet sufficiently diverse, targets would create selection pres-
sure for isolating aptamers that tolerate variations at all
such sites, greatly increasing the likelihood that the isolated
aptamer will have high cross-reactivity to this family as a
whole. Thus, to isolate class-specific synthetic cathinone-
binding aptamers, we selected three targets that share the
same core structure but have variations at all of the substi-
tution sites that are typically modified in this family: alpha-
pyrrolidinovalerophenone (-PVP), ethylone and butylone
(Figure 1A).
Parallel selection
Parallel selection was performed using three different ini-
tial library pools, with one pool being challenged with -
PVP, one with ethylone and one with butylone (Figure 1B,
top). Presumably, challenging the parallel pools with indi-
vidual targets enriches all sequences binding to the target,
including those that are also cross-reactive to other syn-
thetic cathinones. In contrast, challenging a single pool with
a mixture of targets may lead to loss of cross-reactive ap-
tamers. This is evidenced by a previous study that demon-
strated that performing SELEX with a mixture of four tar-
gets yielded aptamers that specifically bind to just one of the
four (26). This may be attributable to competitive binding
among these targets.
To perform parallel selection, we employed a library pool
consisting of ∼6 × 1014 unique oligonucleotide sequences,
which form an 8-bp stem and a 30-nt random loop as
the putative target-binding domain (Supplementary Figure
S1A). During the first round, each initial library pool was
challenged with 1 mM target, and eluted strands were col-
lected and amplified for the next round of selection. To fur-
ther establish class-specificity, from the second round on-
ward we performed counter-SELEX prior to the positive
selection step to remove aptamers binding to structurally
similar interferents (e.g. cocaine, procaine, lidocaine) that
have the same functional groups or partial structural fea-
tures as our targets. In round two, counter-SELEXwas first
performed for each pool against 100 M cocaine, followed
by positive selection with 500 M target, as reducing tar-
get concentration increases selection stringency (27–29). In
the third round, a mixture of 100 M cocaine and 100 M
procaine was used for counter-SELEX, with the same tar-
get concentration for positive selection. In rounds four and
five, counter-SELEX was performed against cocaine, pro-
caine and lidocaine (each at a concentration of 100 M) in
amixture, with 250Mtarget used for the positive selection
step.
After the fifth round, a gel-elution assay (see ‘Materi-
als and methods’ section) was performed to determine the
target-binding affinity of each pool for its respective tar-
get. We observed that the fraction of eluted library in-
creased with increasing target concentrations for the ethy-
lone and butylone pools (Supplementary Figures S3A and
S4A), showing that aptamers binding to these targets had
been enriched through parallel selection. In contrast, target
elution remained low for the -PVP pool (Supplementary
Figure S5A) regardless of the employed concentration of
target, which indicated that the pool was not yet enriched.
We further determined the cross-reactivity and specificity
of the three pools via the gel-elution assay. The enriched
ethylone and butylone pools were able to bind to both ethy-
lone and butylone, but not to -PVP, which indicated that
the population of cross-reactive aptamers was relatively low.
These pools also showed some affinity to procaine, with the
ethylone pool also binding to cocaine. Neither pool dis-
played any affinity for lidocaine (Supplementary Figures
S3B and S4B). In contrast, the -PVP pool showed no affin-
ity for any of the targets or counter-targets (Supplementary
Figure S5B).
Given that the -PVP pool was not yet enriched, we per-
formed additional rounds of selection. From rounds six
to eight, we used the same counter-target mixture of 100
M cocaine, procaine and lidocaine from round 5 with a
further-reduced -PVP concentration of 100 M for pos-
itive selection. For the ninth round, we used the same -
PVP concentration but with counter-selection performed
with 300 M of each of the three counter-targets in a con-
secutive manner. After the ninth round, we performed the
gel-elution assay with the enriched pool and observed a
clear target concentration-dependent elution profile for -
PVP, with an estimated dissociation constant (KD) of 28
M (Supplementary Figure S6A). Notably, only 30% of
the library was eluted, even in the presence of 1 mM -
PVP, which implied that there was just a small population of
binders in the pool. We also determined that this pool dis-
played affinity to ethylone and butylone but was less respon-
sive toward the various interferents (Supplementary Figure
S6B), which can be attributed to the fact that more rounds
of counter-SELEX were performed. Given that the pools
enriched with individual targets also cross-reacted to other
targets, it seemed likely that those pools contained cross-
reactive aptamers. We believed that if parallel selection was
continued, target-specific aptamers would have begun to
dominate the pool; therefore, we terminated parallel selec-
tion before this could occur.
Serial selection
We then performed serial selection to enrich cross-reactive
aptamers and exclude those specific to individual targets
(Figure 1B, bottom). We combined all three enriched par-
allel pool as a starting library. For each cycle of serial se-
lection, we challenged the combined pool with each target
sequentially for a total of three rounds of selection using
butylone (first round), ethylone (second round) and -PVP
(third round). In each round, we first performed counter-
SELEX with 500 M cocaine, procaine and lidocaine se-
quentially followed by positive selection with 100 M tar-
get. After the first cycle of serial selection against all three
targets, we performed the gel-elution assay to determine the
cross-reactivity and specificity of the resulting pool. We ob-
served that the cross-reactivity toward ethylone and buty-
lone had substantially increased (KD = 82 and 77 M,
respectively) relative to the individual pools obtained for
these targets at the end of parallel selection, while affinity
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toward -PVP was essentially unchanged (KD = 34 M)
(Supplementary Figure S7A). Importantly, this pool ex-
hibited greatly improved specificity, with minimal affinity
for cocaine and lidocaine and only a moderate response to
procaine (Supplementary Figure S7B). We then performed
a second cycle of serial selection with an identical selec-
tion procedure but with a three-stage counter-SELEX pro-
cess entailing sequential screening against a mixture of 500
M each of ephedrine, pseudoephedrine, acetaminophen,
methamphetamine, amphetamine, then a mixture of 1 mM
each of cocaine, procaine and lidocaine, and finally with
500 M promazine. We believe that the inclusion of these
additional counter-targets, which are similar in structure to
synthetic cathinones and commonly encountered in seized
substances, further enhances the specificity of the enriched
pool. After this cycle, we again evaluated the pool bind-
ing affinity via the gel-elution assay (Figure 2A). Each indi-
vidual target (at a concentration of 500 M) eluted more
than 70% of the pool. The pool affinity toward ethylone
and butylone had increased by ∼10-fold (KD = 6.9 and 9.5
M, respectively), whereas the affinity toward -PVP only
marginally increased (KD = 21 M).
Characterization and sequencing of the final serial pool
We concluded that at this stage, the enriched pool largely
comprised of cross-reactive synthetic cathinone-binding ap-
tamers. To confirm this, we used the gel-elution assay to
test the cross-reactivity of this pool by challenging it with
the three targets as well as 11 other synthetic cathinones
(for names and chemical structures, see Supplementary Fig-
ure S8A). All of them demonstrated >60% target elution
at a concentration of 50 M (Figure 2B). This shows that
the aptamer could recognize the core structure of synthetic
cathinones, while being tolerant even to side-chain sub-
stituents that were not encountered during SELEX. To eval-
uate the specificity of the enriched pool, we challenged the
pool with 50 M of the counter targets and other poten-
tial interferents (for chemical structures, see Supplemen-
tary Figure S8B) and found that none of them showed in-
creased elution compared with buffer alone (Figure 2B).
We therefore cloned and sequenced this final enriched pool.
The pool was revealed to have low diversity, with 30 of the
50 clones having an identical sequence, which we named
SCA2.1 (Supplementary Table S5). Mfold (30) predicts that
SCA2.1 has a stem–loop structure with a 9-bp stem and a
28-nt loop in our selection buffer at room temperature (Sup-
plementary Figure S9).
High-throughput sequencing (HTS) analysis of the selection
process
We performed a thorough investigation of the parallel-
and-serial selection process using HTS. Specifically, we se-
quenced our three final parallel pools (butylone P5, ethy-
lone P5 and -PVP P9) and two serial pools (S3 and S6)
(Figure 3). Analysis of the parallel pools showed that the
most prevalent sequence represented 0.0079% (butylone
P5), 0.0012% (ethylone P5) and 4.6% (-PVP P9) of their
respective pool. The greater enrichment observed in the -
PVP P9 pool is probably due to the additional four rounds
of parallel selection. Nevertheless, no particular sequence
dominated any of these parallel pools, which indicated that
they were not yet highly enriched. Meanwhile, the SCA2.1
family (see ‘Materials and methods’ section) comprised
0.011% of the butylone P5 pool and 0.00095% of the -PVP
P9 pool, which is notably higher than the median sequence
abundance in each pool (0.00019% for butylone P5 and
0.00032% for -PVP P9), showing that parallel selection en-
riches cross-reactive aptamers. We noted that ethylone P5
pool did not show any signs of enrichment. To determine if
cross-reactive aptamers were present or lost in the ethylone
pool, we performed an additional three rounds of parallel
selection for this pool and then performed high-throughput
sequencing with the resulting ethylone P8 pool. We found
that the SCA2.1 family represented 0.1% of this pool, which
implies that these sequences were originally present in the
ethylone P5 pool, but at an amount below the detection ca-
pability of the HTS method we employed.
Upon combining the three parallel pools, the SCA2.1
family consisted of 0.0041% of the combined pool (me-
dian population: 0.000086%) based on our sequencing data.
Such enrichment allowed for exponential enrichment of
cross-reactive aptamers during serial selection, wherein the
population of the SCA2.1 family increased to 0.39% of the
S3 pool and 29% of the S6 pool. Indeed, parallel selection
made serial selection highly efficient. It is likely that per-
forming serial selection without parallel selection would re-
sult in loss of cross-reactive aptamers, given the generally
low copy number of such sequences in initial rounds.
Characterization of the affinity and specificity of the isolated
aptamer
We then characterized the affinity of SCA2.1 for the se-
lection targets and specificity against interferents using
isothermal titration calorimetry (ITC). We titrated a 300–
400 M solution of target into a 20 M solution of the ap-
tamer, recorded the heat released by each titration and inte-
grated these data to generate a binding curve. Curve fitting
with a one-site binding model resulted in atypical binding
stoichiometries (N) and less-than-optimal fitting, especially
for the-PVP titration curve that has a non-sigmoidal curve
(Supplementary Figure S10 and Supplementary Table S3).
Given that synthetic cathinones are chiral molecules and a
racemicmixture of the targets was employed for SELEX,we
hypothesized that the aptamer may have differential bind-
ing affinity for each enantiomer. The pure enantiomers of
the three selection targets were not commercially available,
but the high cross-reactivity of the aptamer allowed us to
use enantiomers for another synthetic cathinone, (−)- and
(+)-MDPV, to confirm our hypothesis. ITC data indicated
that the aptamer binds to one targetmolecule, withN= 0.92
and 0.95 for (−)- and (+)-MDPV, respectively, and exhibits
100-fold greater affinity for the (−) enantiomer (KD = 46.5
± 7.5 nM) relative to the (+) enantiomer (KD = 3.61 ± 0.12
M) (Figures 4A and B and Supplementary Table S4). We
also performed ITC by titrating racemicMDPV into a solu-
tion of SCA2.1 and observed a binding curve similar in ap-
pearance to that of-PVP.Using amodified two-set-of-sites
model (see ‘Supplementary materials and methods’ for de-
tail) to fit the result (Figure 4C), we obtained similar bind-
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Figure 2. Characterization of the affinity and specificity of the final enriched pool via a gel-elution assay. (A) PAGE results depict the target elution profile,
with lanes representing samples of the pool eluted with 0, 10, 50, 100, 250, 500 or 1000 M (from left to right) -PVP, ethylone or butylone. The percent
of target-eluted pool was plotted against the concentration of target to determine the binding affinity of the enriched pool. (B) Percent elution values for
14 synthetic cathinones and 11 interferents at a concentration of 50 M and buffer alone.
Figure 3. Box and whisker plots of the population distribution of se-
quences after parallel selection (butylone P5, ethylone P5, ethylone P8 and
-PVP P9) and each round of serial selection (S3 and S6) are shown. The
longest horizontal line indicates the 50th percentile, with the boundaries
of the box indicating the 5th and 95th percentile, and the whiskers indi-
cate the highest and lowest values of the results. Sequences with popula-
tion above 95th percentile are plotted as gray dots. The total population
of SCA2.1 family is plotted as a red dot in each pool, except for the ethy-
lone P5 pool where no such sequences were detected. Inset shows the pool
population distribution after eight rounds of parallel selection using ethy-
lone as target. Given the high diversity of the parallel pools, the lowest
values 5th, 50th and 95th percentile all overlap, thus the box and lowest
whisker cannot be seen. For the serial pools, the lowest values, 5th, and
50th percentile overlap, thus the bottom portion of the box and the lowest
whisker are likewise not apparent.
ing parameters to those produced by the titration of each
enantiomer alone (Supplementary Table S4, (±)-MDPV).
This confirmed that the modified model is appropriate to
describe such binding phenomenon.
We then used this modified two-set-of-sites model to fit
the ethylone, butylone and -PVP binding curves, and ob-
tained improved fitting and normalN values (0.9–1.1), with
nanomolar affinity toward one enantiomer andmicromolar
affinity for the other (Figure 5 and Supplementary Table
S3). Opposing intuition, these results suggest that SCA2.1
can achieve not only high target cross-reactivity, but also
superior binding affinity. To determine the specificity of
Figure 4. Characterization of the synthetic cathinone-binding affinity of
SCA2.1 using ITC. Top panels present raw data showing the heat generated
from each titration of (A) (−)-MDPV, (B) (+)-MDPV and (C) (±)-MDPV
to SCA2.1, while bottom panels show the integrated heat of each titration
after correcting for dilution heat of the titrant. ITC data obtained with
(−)-MDPV and (+)-MDPV were fitted using a single-site model, and ITC
data obtainedwith (±)-MDPVwere fittedwith amodified two-site binding
model. All binding parameters are shown in Supplementary Table S4.
Figure 5. Characterization of the target-binding affinity of SCA2.1 using
ITC. Top panels present raw data showing the heat generated from each
titration of (A) -PVP, (B) ethylone and (C) butylone to SCA2.1, while
bottom panels show the integrated heat of each titration after correcting
for dilution heat of the titrant. ITCdatawere fittedwith amodified two-site
binding model and the binding parameters are shown in Supplementary
Table S3.
SCA2.1, we performed ITC with interferents that are most
structurally similar to synthetic cathinones including am-
phetamine, methamphetamine, ephedrine, cocaine and pro-
caine. All such compounds had very low binding affinity for
SCA2.1 (Supplementary Figure S11).
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Evaluating the target-binding spectrum and specificity of the
isolated aptamer
We then demonstrated the analytical utility of SCA2.1 in
a colorimetric dye-displacement assay. Diethylthiotricarbo-
cyanine (Cy7) is a small-molecule dye that exists in equi-
librium between monomer and dimer forms, which have
absorbance peaks at 760 and 670 nm, respectively. Previ-
ous studies have shown that Cy7 monomers can bind to
hydrophobic target-binding domains of aptamers, which
results in strong enhancement of absorbance at 760 nm
(22,31). However, the binding of target to the aptamer can
displaceCy7monomer from the binding domainwithin sec-
onds, which causes the dye to dimerize in aqueous solu-
tion, resulting in the reduction of absorbance at 760 nm
and enhancement of absorbance at 670 nm (Supplemen-
tary Figure S12). This approach can thus be used as a col-
orimetric indicator for small molecule detection. We first
examined if such an assay can be employed to detect syn-
thetic cathinones using SCA2.1.We determined the binding
affinity of Cy7 to SCA2.1 by titrating different concentra-
tions of the aptamer into a solution of 2 M Cy7 (Supple-
mentary Figure S13A). Increasing the amount of aptamer
progressively enhanced the absorbance of Cy7 monomer
at ∼760 nm, indicating binding to the aptamer. A gradual
peak shift from 760 to 775 nm was also observed, which
is consistent with previous studies (22,31) showing that ab-
sorbance of the monomer can change in different microen-
vironments, such as when the dye binds to the aptamer.
Based on Cy7 absorbance at 775 nm, we obtained a KD
of 1.6 M (Supplementary Figure S13B). We then investi-
gated whether the synthetic cathinone targets can efficiently
displace Cy7 from SCA2.1. We first titrated different con-
centrations of butylone into a mixture of 2 M Cy7 and 3
M SCA2.1, and found that increasing concentrations of
butylone progressively reduced the absorbance of Cy7 at
775 nmwhile enhancing absorbance at 670 nm (Supplemen-
tary Figure S14A). This change can be attributed to dimer-
ization of the Cy7 monomer when displaced from the ap-
tamer into solution (22,31). We used the absorbance ratio
between 670 and 775 nm (A670/A775) to calculate signal gain
and generate a calibration curve, which displayed a linear
range of 0 to 10 M and a measurable detection limit of
250 nM (Supplementary Figure S15). We obtained equiv-
alent results with both ethylone and -PVP (Supplemen-
tary Figures S14B,C and S15), again confirming the high
cross-reactivity of SCA2.1. The Cy7-displacement assay is
also compatible with biosamples such as urine and saliva,
since the absorbance range of Cy7 is well outside the back-
ground absorbance exhibited by these matrices (22). We
obtained calibration curves with ethylone spiked into 50%
urine (Supplementary Figure S16) and 50% saliva (Supple-
mentary Figure S17) with a linear range of 0 to 10Mand a
measurable detection limit of 80 and 120 nM, respectively.
The enhanced sensitivity of the assay in these biomatrices
can be possibly attributed to the higher ionic strength of the
media, whichmay enhance target-binding to the aptamer or
Cy7 dimerization.
We tested the cross-reactivity of this assay for nine other
synthetic cathinones, including naphyrone, MDPV, penty-
lone, methylone, 4-MMC, 4-FMC, 3-FMC, methcathinone
and cathinone at a concentration of 50 M. As expected,
despite the diversity of the side chains substituents, all syn-
thetic cathinones induced a significant change inA670/A775,
producing a signal gain ranging from 45% to 130% rel-
ative to ethylone (Figure 6A). This implies that SCA2.1
mainly recognizes the -keto phenethylamine core struc-
ture, and variations in the side chains do not significantly
affect target-binding affinity. Notably, the aptamer is more
cross-reactive to a broad range of synthetic cathinones than
antibodies used in existing immunoassays, which achieve
>20% cross-reactivity for only five synthetic cathinones
(32). SCA2.1 shows a moderate bias toward bulkier syn-
thetic cathinones such asMDPV, naphyrone and pentylone.
Such ligands may fit better in the binding pocket compared
to smaller synthetic cathinones like methcathinone or 4-
FMC, achieving high binding affinity through greater in-
teraction with the aptamer. This supports the higher sig-
nal gain observed in the assay. Importantly, our assay has
excellent specificity, as the aptamer does not cross-react to
non-synthetic cathinone interferents. We tested our assay
with 11 different interferent compounds, including com-
mon illicit drugs (amphetamine, methamphetamine and co-
caine) and cutting agents found in street samples (pseu-
doephedrine, ephedrine, procaine, lidocaine, benzocaine,
caffeine, acetaminophen and sucrose) at a concentration of
50 M. The assay yielded no response to any of these inter-
ferents (Figure 6A), even though many contained a partial
-keto phenethylamine structure, demonstrating that ap-
tamer specificity can be precisely controlled through a well-
designed selection approach.
We finally determined the limit of detection for our Cy7-
displacement assay for 12 synthetic cathinones and ob-
served detection limits that varied from 40 to 80 nM in 50%
urine (Supplementary Figure S18). Clearly, the high affin-
ity of this aptamer as well as its unresponsiveness toward
endogenous compounds enables sensitive screening of syn-
thetic cathinones in biological samples. Given that the con-
centration of these drugs in urine typically ranges between
high nanomolar to <100 Mwithin a few hours after con-
sumption (33), we believe that our assay will be useful for
label-free detection of synthetic cathinones in these matri-
ces.
We further fine-tuned our Cy7-displacement assay by us-
ing a higher concentration of the dye and aptamer in order
to intensify the target-induced color change and thereby en-
able naked-eye detection. We challenged this assay with the
aforementioned 12 synthetic cathinones and 11 interferent
compounds at a concentration of 50 M with 3.5 M Cy7
and 5 M SCA2.1. In the absence of target, the aptamer-
bound Cy7 monomer has an absorption peak at 775 nm,
which is not in the visible range, and thus the sample is prac-
tically colorless. However, when Cy7 is displaced by the tar-
get, the resulting dimerization-associated absorption peak
at 670 nm causes the solution to produce a bright, clearly
visible blue color. We observed that all 12 synthetic cathi-
nones immediately induced a clear-to-blue color change in
the solution, while no color change was identified upon ad-
dition of any of the interferent compounds (Figure 6B).
Using ethylone as a target, we determined that 6.3 M is
the lowest concentration that can develop a color distin-
guishable from the blank with the naked eye (Supplemen-
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Figure 6. Colorimetric detection of synthetic cathinones using a SCA2.1-based Cy7-displacement assay. (A) Signal gain measured via a plate reader from
the Cy7-displacement assay with 12 synthetic cathinones (gray, with the three selection targets shaded) and 11 interferents (white) at a concentration of 50
M with 3 M SCA2.1 and 2 M Cy7. Cross-reactivity is defined as the ratio of signal gain between the reference target ethylone and another synthetic
cathinone or interferentmultiplied by 100%.Error bars show standard deviations from threemeasurements. (B)Naked-eye detection of synthetic cathinones
using a mixture of 5 M SCA2.1 and 3.5 M Cy7. The color of the solution changes to bright blue within seconds upon addition of 50 M synthetic
cathinones (a-l). However, the color appears as a faint blue color in the absence of target (-) or 50 M of a wide range of interferents (m-w).
tary Figure S19). These results demonstrate the feasibility
of the Cy7-displacement assay for instrument-free on-site
drug screening applications.
DISCUSSION
Class-specificity implies a degree of both receptor promis-
cuity toward targets within a designated molecular family
and specificity against molecules outside of the family. The
development of class-specific antibodies and aptamers has
proven challenging due to the lack of viable methods to
precisely control receptor binding profiles and specificity.
In this work, we sought to develop a new aptamer isola-
tion strategy, parallel-and-serial selection, as an effective
way to select for class-specific aptamers recognizing small
molecules based on a familial molecular core structure. The
parallel-and-serial selection strategy increases the likeli-
hood of isolating broadly cross-reactive aptamers by enrich-
ing oligonucleotide pools in parallel against diversely struc-
tured members of the designated target family and then
combining and challenging the pools serially with these tar-
gets to fine tune specificity toward a particular class of tar-
gets. Here, we chose three synthetic cathinones that vary
at all major substituent sites of the targeted family to en-
sure that broadly cross-reactive aptamers are isolated.Other
target triplets could yield equally cross-reactive aptamers if
they are sufficiently diverse. More targets can be employed
to create broader cross-reactivity, although this will increase
labor and cost requirements. By supplementing our strat-
egy with counter-SELEX, the binding spectrum can be nar-
rowed down to the target family, thereby avoiding unwanted
cross-reactivity to structurally similar non-target molecules.
As a demonstration, we isolated a single class-specific
DNA aptamer that can bind to 12 diverse synthetic cathi-
nones. This aptamer is insensitive to variations at all sub-
stituent sites on the core structure, and even tolerates many
substituents that do not appear in our selection targets. Im-
portantly, our aptamer does not respond to 11 structurally
similar compounds, some of which only differ from our tar-
gets by a single atom. We subsequently demonstrated the
superior class-specificity and affinity of our aptamer in a
single-step, colorimetric Cy7-displacement assay, which can
detect clinically relevant concentrations of synthetic cathi-
nones in biomatrices (33–35) and presents greater target
cross-reactivity than existing antibodies. Advantageously,
this assay can also achieve naked-eye detection of synthetic
cathinones at concentrations at low micromolar concentra-
tions, which is valuable for on-site screening of seized sub-
stances.
The aptamer isolated herein displays binding charac-
teristics that confound intuition. This aptamer has great
molecular promiscuity, binding to several molecules shar-
ing a common, defined core structure. All the while, the ap-
tamer retains the ability to discriminate against non-target
molecules that are closely related in structure to members
of the designated target family, even by a single atom differ-
ence in certain instances. Impressively, the aptamer also can
bind to its targets with nanomolar affinity. This was not as
expected, as broad cross-reactivity and high affinity is, on
the surface, counter-intuitive.
Our findings significantly expand the capability of
aptamers as class-specific biorecognition elements and
demonstrate an unprecedented level of control over ap-
tamer binding profiles through this new parallel-and-serial
selection strategy. We believe that our approach can be used
to isolate class-specific aptamers for other families of small
molecules for applications relevant to medical diagnostics,
environmental monitoring, food safety and forensic science.
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Supplementary Data are available at NAR Online.
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